Adverse events to the nimotuzumab in patients with primary cerebral tumor

Introduction: The nimotuzumab is a monoclonal antibody used in the treatment of patients with cerebral tumor. The realization of pharmaco surveillance studies that guaranteed its security is justified given its new features.   Objective: To characterize the adverse events related to this medicine in...

Full description

Saved in:
Bibliographic Details
Main Authors: Yasley Gámez Fernández (Author), Leonardo Ramos Hernández (Author), Soraida Cándida Acosta Brooks (Author), Sandra Peacok Aldana (Author)
Format: Book
Published: Centro Provincial de Información de Ciencias Médicas, 2022-01-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available